sulfisoxazole has been researched along with clindamycin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Marks, MI | 1 |
Digout, G; Haldane, EV; Haldane, JH; van Rooyen, CE; West, A | 1 |
Trautmann, A | 1 |
Jackson, EA; McLeod, DC | 1 |
8 other study(ies) available for sulfisoxazole and clindamycin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.
Topics: Ampicillin; Bacteria; Cephalexin; Clindamycin; Cloxacillin; Drug Synergism; Erythromycin; Haemophilus influenzae; Lincomycin; Microbial Sensitivity Tests; Penicillin G; Staphylococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Sulfamethoxazole; Sulfisoxazole; Sulfonamides | 1975 |
Streptococcus bovis endocarditis.
Topics: Aortic Valve Insufficiency; Clindamycin; Diabetes Complications; Drug Hypersensitivity; Endocarditis, Bacterial; Heart Failure; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Streptococcal Infections; Streptococcus; Sulfisoxazole; Vancomycin | 1974 |
[Dialysis of drugs and poisons. 3].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antimalarials; Antitubercular Agents; Cephaloridine; Cephalosporins; Chloramphenicol; Chlortetracycline; Clindamycin; Humans; Kanamycin; Lincomycin; Neomycin; Penicillins; Poisoning; Renal Dialysis; Streptomycin; Sulfadiazine; Sulfamethoxypyridazine; Sulfathiazoles; Sulfisoxazole; Tetracycline | 1972 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |